Eur Respir J 2006; 27:172-187
Copyright ©ERS Journals Ltd 2006
Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma
G. Horvath1,2 and
A. Wanner1
1 Division of Pulmonary and Critical Care Medicine, University of Miami School of Medicine, Miami, FL, USA, and 2 Dept of Respiratory Medicine, Semmelweis University Budapest, School of Medicine, Hungary.
CORRESPONDENCE: A. Wanner, Division of Pulmonary and Critical Care Medicine, University of Miami School of Medicine, P.O. Box 016960 (R-47), Miami, FL 33101, USA. Fax: 1 3052436992. E-mail: AWanner{at}med.miami.edu
Keywords: Airway vascularity, angiogenesis, asthma, inhaled corticosteroids, nongenomic action, vasoconstriction
Received: April 21, 2005
Accepted July 22, 2005
Inhaled corticosteroids suppress airway inflammation and components of airway remodelling in bronchial asthma. In the tracheobronchial (airway) vasculature, these include the inhibition of inflammatory hyperperfusion, microvascular hyperpermeability, mucosal oedema formation, and the formation of new blood vessels (angiogenesis).
Corticosteroids are now known to exert their effects on the airway vasculature through genomic and nongenomic mechanisms. Genomic actions involve the regulation of target genes, and suppress most of the vascular elements of inflammation and angiogenesis in the airway. In contrast, nongenomic actions are mediated by rapid cellular mechanisms, and induce transient vasoconstriction in the airway, thereby reversing inflammatory hyperperfusion.
The vascular actions of corticosteroids contribute to controlling clinical symptoms of asthma primarily by influencing airway calibre in the lung periphery and airway hyperreactivity.
In this review article, recent advances into the understanding of cellular mechanisms and the clinical implications of the interaction of inhaled corticosteroids and the airway vasculature in asthma are reviewed.
This article has been cited by other articles:

|
 |

|
 |
 
A S Pelkonen, K Malmstrom, L P Malmberg, S Sarna, M Turpeinen, M Kajosaari, T Haahtela, and M J Makela
Budesonide improves decreased airway conductance in infants with respiratory symptoms
Arch. Dis. Child.,
July 1, 2009;
94(7):
536 - 541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Vieira, V. F. de Andrade, A. C. S. Duarte, A. B. G. dos Santos, T. Mauad, M. A. Martins, M. Dolhnikoff, and C. R. F. Carvalho
Aerobic conditioning and allergic pulmonary inflammation in mice. II. Effects on lung vascular and parenchymal inflammation and remodeling
Am J Physiol Lung Cell Mol Physiol,
October 1, 2008;
295(4):
L670 - L679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zanini, A. Chetta, and D. Olivieri
Review: Therapeutic perspectives in bronchial vascular remodeling in COPD
Therapeutic Advances in Respiratory Disease,
June 1, 2008;
2(3):
179 - 187.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Zani, K. Kojima, C. A. Vacanti, and E. R. Edelman
Tissue-engineered endothelial and epithelial implants differentially and synergistically regulate airway repair
PNAS,
May 13, 2008;
105(19):
7046 - 7051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Horvath, E. S. Mendes, N. Schmid, A. Schmid, G. E. Conner, M. Salathe, and A. Wanner
Rapid corticosteroid effect on long-acting {beta}2-agonist disposal by smooth muscle cells in the airway: a new paradigm of inhaled combination therapy
Eur. Respir. Rev.,
April 1, 2008;
17(107):
41 - 42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Wagner, J. Sanchez, J. Y. McClintock, J. Jenkins, and A. Moldobaeva
Inflammation and ischemia-induced lung angiogenesis
Am J Physiol Lung Cell Mol Physiol,
February 1, 2008;
294(2):
L351 - L357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Horvath, N. Schmid, M. A. Fragoso, A. Schmid, G. E. Conner, M. Salathe, and A. Wanner
Epithelial Organic Cation Transporters Ensure pH-Dependent Drug Absorption in the Airway
Am. J. Respir. Cell Mol. Biol.,
January 1, 2007;
36(1):
53 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Rodrigo
Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation.
Chest,
November 1, 2006;
130(5):
1301 - 1311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Slats, J. K. Sont, R. H.C.J. van Klink, E. H.D. Bel, and P. J. Sterk
Improvement in bronchodilation following deep inspiration after a course of high-dose oral prednisone in asthma.
Chest,
July 1, 2006;
130(1):
58 - 65.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the European Respiratory Society.
|